Francisco Eduardo Cardoso

Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort

Henry Mauricio Chaparro-Solano, Daniel Teixeira-Dos-Santos, Emily Waldo, Thiago Peixoto Leal et autres

BackgroundAlthough levodopa is the gold standard treatment for Parkinson's disease (PD), its chronic use is associated with levodopa-induced dyskinesia (LID), a motor complication that impacts prognosis, quality of life, and treatment costs. Most known LID-associated factors have been identified in European-descendant populations.ObjectivesTo …

us, br, mx, pe, cl, co, pt, sv, ar, pr (code pays fourni par la source)

Inflammation and neurotrophic dysregulation in progressive supranuclear palsy

Erica Vieira, Natalia Rocha, Paulo Caramelli, Aline Miranda et autres

ca, us, br, ae (code pays fourni par la source)